Notification
No new Notification messages
Niva Bupa Health Insurance IPO is Open!
Apply for the Niva Bupa Health Insurance IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
thyrocare tech ltd stock

THYROCARE TECH LTD Share Price

978 10.70 (1.10%)
Nov 08 2024 03:30 PM Healthcare NSE: THYROCARE

THYROCARE TECH LTD Share Price Update

As of the latest trading session, THYROCARE TECH LTD share price is currently at 978, which is up by 10.70 from its previous closing. Today, the stock has fluctuated between 950.15 and 998.55. Over the past year, THYROCARE TECH LTD has achieved a return of 80.25 %. In the last month alone, the return has been 18.89 %. Read More...

THYROCARE TECH LTD Performance

Day Range

Low950.15 High998.55
978.00

52 Week Range

Low 533.50 High 985.00
978.00

THYROCARE TECH LTD Share Price

17032

539871

THYROCARE

img img img img
No Data Available

Open Price

973.10

Prev. Close

967.30

Volume (Shares)

217511.00

Total traded value

2127.25

Upper Circuit

1160.75

Lower Circuit

773.85

Note: The current prices & values are delayed, Login to your account for live updates.

THYROCARE TECH LTD Fundamentals


(Standalone)

Market Cap (Cr) 5178.77
PE Ratio (TTM) 58.44
Book Value / Share 90.45
Beta 0.50
ROE 13.75%
EPS (TTM) 16.77
Dividend Yield 1.84%
Net Profit Qtr (Cr) 29.59

THYROCARE TECH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 163.05
Operating Expense 124.83
Net Profit 29.59
Net Profit Margin (%) 18.14
Earnings Per Share (EPS) 5.59
EBITDA 50.91
Effective Tax Rate (%) 26.64
Particulars JUN 2024 (Values in Cr)
Revenue 143.63
Operating Expense 111.66
Net Profit 25.15
Net Profit Margin (%) 17.51
Earnings Per Share (EPS) 4.75
EBITDA 45.51
Effective Tax Rate (%) 28.42
Particulars MAR 2024 (Values in Cr)
Revenue 141.23
Operating Expense 118.99
Net Profit 19.23
Net Profit Margin (%) 13.61
Earnings Per Share (EPS) 3.63
EBITDA 36.40
Effective Tax Rate (%) 23.23
Particulars DEC 2023 (Values in Cr)
Revenue 122.89
Operating Expense 104.22
Net Profit 14.89
Net Profit Margin (%) 12.11
Earnings Per Share (EPS) 2.81
EBITDA 32.62
Effective Tax Rate (%) 28.27
Particulars SEP 2023 (Values in Cr)
Revenue 136.29
Operating Expense 109.97
Net Profit 20.29
Net Profit Margin (%) 14.88
Earnings Per Share (EPS) 3.83
EBITDA 38.45
Effective Tax Rate (%) 27.87
Particulars MAR 2024 (Values in Cr)
Revenue 524.02
Operating Expense 432.98
Net Profit 71.14
Net Profit Margin (%) 13.57
Earnings Per Share (EPS) 13.44
EBITDA 141.06
Effective Tax Rate (%) 27.57
Particulars MAR 2023 (Values in Cr)
Revenue 486.46
Operating Expense 410.78
Net Profit 56.97
Net Profit Margin (%) 11.71
Earnings Per Share (EPS) 10.77
EBITDA 117.39
Effective Tax Rate (%) 29.72
Particulars MAR 2022 (Values in Cr)
Revenue 561.53
Operating Expense 361.55
Net Profit 152.05
Net Profit Margin (%) 27.07
Earnings Per Share (EPS) 28.75
EBITDA 238.23
Effective Tax Rate (%) 26.68
Particulars MAR 2021 (Values in Cr)
Revenue 474.27
Operating Expense 325.27
Net Profit 119.77
Net Profit Margin (%) 25.25
Earnings Per Share (EPS) 22.66
EBITDA 183.01
Effective Tax Rate (%) 25.73
Particulars MAR 2020 (Values in Cr)
Revenue 400.00
Operating Expense 254.15
Net Profit 79.32
Net Profit Margin (%) 19.83
Earnings Per Share (EPS) 15.02
EBITDA 132.85
Effective Tax Rate (%) 29.17
Particulars MAR 2024 (Values in Cr)
Book Value / Share 93.02
ROE % 13.10
ROCE % 17.92
Total Debt to Total Equity 0.06
EBITDA Margin 25.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 97.37
ROE % 12.13
ROCE % 16.86
Total Debt to Total Equity 0.04
EBITDA Margin 25.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 99.54
ROE % 33.05
ROCE % 41.39
Total Debt to Total Equity 0.03
EBITDA Margin 40.79
Particulars MAR 2021 (Values in Cr)
Book Value / Share 80.82
ROE % 28.50
ROCE % 36.66
Total Debt to Total Equity 0.03
EBITDA Margin 37.12
Particulars MAR 2020 (Values in Cr)
Book Value / Share 69.39
ROE % 22.05
ROCE % 33.82
Total Debt to Total Equity 0.02
EBITDA Margin 40.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share 90.58
ROE % 13.75
ROCE % 18.63
Total Debt to Total Equity 0.06
EBITDA Margin 27.14
Particulars MAR 2023 (Values in Cr)
Book Value / Share 94.86
ROE % 10.94
ROCE % 15.73
Total Debt to Total Equity 0.04
EBITDA Margin 24.60
Particulars MAR 2022 (Values in Cr)
Book Value / Share 98.43
ROE % 31.48
ROCE % 41.64
Total Debt to Total Equity 0.03
EBITDA Margin 42.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.26
ROE % 29.08
ROCE % 37.49
Total Debt to Total Equity 0.02
EBITDA Margin 38.59
Particulars MAR 2020 (Values in Cr)
Book Value / Share 71.58
ROE % 24.88
ROCE % 35.60
Total Debt to Total Equity 0.01
EBITDA Margin 42.98
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 39.89
Total Assets 643.88
Total Liabilities 643.88
Total Equity 527.63
Share Outstanding 52952676
Price to Book Ratio 6.54
Return on Assets (%) 10.98
Return on Capital (%) 12.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.47
Total Assets 632.72
Total Liabilities 632.72
Total Equity 535.22
Share Outstanding 52930043
Price to Book Ratio 4.53
Return on Assets (%) 10.19
Return on Capital (%) 12.05
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 13.91
Total Assets 607.66
Total Liabilities 607.66
Total Equity 526.57
Share Outstanding 52903332
Price to Book Ratio 7.86
Return on Assets (%) 28.98
Return on Capital (%) 33.45
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 15.73
Total Assets 545.80
Total Liabilities 545.80
Total Equity 427.28
Share Outstanding 52871371
Price to Book Ratio 10.72
Return on Assets (%) 20.73
Return on Capital (%) 26.48
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 11.07
Total Assets 470.88
Total Liabilities 470.88
Total Equity 366.65
Share Outstanding 52833000
Price to Book Ratio 6.92
Return on Assets (%) 18.77
Return on Capital (%) 23.95
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 34.10
Total Assets 620.27
Total Liabilities 620.27
Total Equity 513.81
Share Outstanding 52952676
Price to Book Ratio 6.54
Return on Assets (%) 11.46
Return on Capital (%) 13.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 16.39
Total Assets 611.87
Total Liabilities 611.87
Total Equity 521.04
Share Outstanding 52930043
Price to Book Ratio 4.53
Return on Assets (%) 9.31
Return on Capital (%) 10.93
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.00
Total Assets 597.17
Total Liabilities 597.17
Total Equity 520.70
Share Outstanding 52903332
Price to Book Ratio 7.86
Return on Assets (%) 25.46
Return on Capital (%) 29.2
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.67
Total Assets 527.79
Total Liabilities 527.79
Total Equity 445.46
Share Outstanding 52874419
Price to Book Ratio 10.72
Return on Assets (%) 22.69
Return on Capital (%) 26.89
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.30
Total Assets 442.39
Total Liabilities 442.39
Total Equity 378.23
Share Outstanding 52836000
Price to Book Ratio 6.92
Return on Assets (%) 17.92
Return on Capital (%) 20.97
Particulars MAR 2024 (Values in Cr)
Net Income 95.59
Cash from Operations 196.61
Cash from Investing -91.28
Cash from Financing -84.81
Net change in Cash -8.47
Free Cash Flow 258.19
Particulars MAR 2023 (Values in Cr)
Net Income 87.41
Cash from Operations 157.77
Cash from Investing -38.99
Cash from Financing -86.18
Net change in Cash 4.14
Free Cash Flow 201.42
Particulars MAR 2022 (Values in Cr)
Net Income 227.90
Cash from Operations 170.17
Cash from Investing -23.57
Cash from Financing -89.41
Net change in Cash 0.43
Free Cash Flow 208.00
Particulars MAR 2021 (Values in Cr)
Net Income 152.54
Cash from Operations 157.94
Cash from Investing -48.66
Cash from Financing -61.58
Net change in Cash 4.49
Free Cash Flow 184.63
Particulars MAR 2020 (Values in Cr)
Net Income 146.48
Cash from Operations 212.39
Cash from Investing 0.95
Cash from Financing -164.78
Net change in Cash 4.05
Free Cash Flow 222.29
Particulars MAR 2024 (Values in Cr)
Net Income 98.22
Cash from Operations 184.18
Cash from Investing -80.29
Cash from Financing -83.71
Net change in Cash -8.81
Free Cash Flow 227.45
Particulars MAR 2023 (Values in Cr)
Net Income 81.07
Cash from Operations 148.72
Cash from Investing -31.65
Cash from Financing -87.50
Net change in Cash 0.87
Free Cash Flow 169.84
Particulars MAR 2022 (Values in Cr)
Net Income 207.38
Cash from Operations 162.00
Cash from Investing -12.32
Cash from Financing -86.91
Net change in Cash 6.45
Free Cash Flow 202.41
Particulars MAR 2021 (Values in Cr)
Net Income 161.28
Cash from Operations 154.66
Cash from Investing -53.09
Cash from Financing -57.81
Net change in Cash 0.17
Free Cash Flow 193.76
Particulars MAR 2020 (Values in Cr)
Net Income 156.33
Cash from Operations 180.58
Cash from Investing 26.84
Cash from Financing -162.65
Net change in Cash 0.52
Free Cash Flow 189.56
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7420.90 90.19 14.23 106701.16 5122.60 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 53.59 0.00 3.36 100.44 44.00 / 107.94
SHREE PACETRONIX LTD. 130.00 20.93 3.48 46.79 118.00 / 368.70
TRANSGENE BIOTEK LTD. 6.55 0.00 4.63 49.63 5.38 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7420.90 95.02 13.02 106701.16 5122.60 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 39.07 0.00 -89.41 29.19 26.57 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5596.20 31.49 6.89 6122.24 2575.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 965.00
  • 26 Days 907.30
  • 10 Days 950.70
  • 50 Days 888.40
  • 12 Days 949.40
  • 100 Days 823.70
  • 20 Days 923.00
  • 200 Days 644.20
967.00
PIVOT
First Resistance 976.30
Second Resistance 985.30
Third Resistance 994.60
First Support 958.00
Second Support 948.70
Third Support 939.70
RSI 67.15
MACD 42.12
Commodity Channel Index (CCI) 103.83
ADX 28.22
Williams % R -14.94

Over 1 Month

down

18.89

Over 3 Months

down

23.07

Over 6 Months

down

58.70

Over 1 Year

down

80.25

Over 3 Years

down

-5.67

Over 5 Years

down

12.29

THYROCARE TECH LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

THYROCARE TECH LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
14.05
Promoter Holdings
71.11
FII
1.92
DII
12.9
Promoter Shares(Pledge Percentage)
100.0
Name Category Shares Shares%
Docon Technologies Private Limited Shareholding of Promoter and Promoter Group 3.7656092E7 71.11
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund Public Shareholding 3736556.0 7.06
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund Public Shareholding 1785136.0 3.37
Quant Mutual Fund - Quant Small Cap Fund Public Shareholding 952392.0 1.8
Api Holdings Limited Shareholding of Promoter and Promoter Group 0.0 0.0

THYROCARE TECH LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-04-20 18.0 Interim 2023-04-20 Equity shares 2022-05-11 15.0 Interim 2022-05-12 Equity shares 2021-06-17 15.0 Final 2021-06-19 Equity shares 2020-11-12 10.0 Interim 2020-11-13 Equity shares 2019-11-21 5.0 Interim 2019-11-22 Equity shares 2019-08-14 20.0 Final 2019-08-18 Equity shares 2018-08-02 5.0 Final 2018-08-04 Equity shares 2018-02-15 5.0 Interim 2018-02-16 Equity shares 2017-08-03 5.0 Final 2017-08-06 Equity shares 2017-02-08 5.0 Interim 2017-02-09 Equity shares 2016-09-01 2.5 Final 2016-09-05 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About THYROCARE TECH LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by THYROCARE TECH LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Thyrocare Technologies Ltd?

Answer Field

The share price of Thyrocare Technologies Ltd for NSE is ₹ 978 and for BSE is ₹ 976.9.

What is the Market Cap of Thyrocare Technologies Ltd?

Answer Field

The market cap of Thyrocare Technologies Ltd for NSE is ₹ 51,78.77 Cr. and for BSE is ₹ 51,72.94 Cr. as of now.

What is the 52 Week High and Low of Thyrocare Technologies Ltd?

Answer Field

The 52 Week High and Low of Thyrocare Technologies Ltd for NSE is ₹ 998.55 and ₹ 533.50 and for BSE is ₹ 998.00 and ₹ 532.95.

How to Buy Thyrocare Technologies Ltd share?

Answer Field

You can trade in Thyrocare Technologies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Thyrocare Technologies Ltd?

Answer Field

The 1 year returns on the stock has been 80.25%.

What is the Current Share Price of Thyrocare Technologies Ltd?

Answer Field

Thyrocare Technologies Ltd share price is for NSE ₹ 978 & for BSE ₹ 976.9 as on Nov 08 2024 03:30 PM.

What is the Market Cap of Thyrocare Technologies Ltd Share?

Answer Field

The market cap of Thyrocare Technologies Ltd for NSE ₹ 51,78.77 & for BSE ₹ 51,72.94 as on Nov 08 2024 03:30 PM.

What is the P/E Ratio of Thyrocare Technologies Ltd Share?

Answer Field

As on Nov 08 2024 03:30 PM the price-to-earnings (PE) ratio for Thyrocare Technologies Ltd share is 58.44.

What is the PB ratio of Thyrocare Technologies Ltd Share?

Answer Field

As on Nov 08 2024 03:30 PM, the price-to-book (PB) ratio for Thyrocare Technologies Ltd share is 90.45.

How to Buy Thyrocare Technologies Ltd Share?

Answer Field

You can trade in Thyrocare Technologies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Thyrocare Technologies Ltd Share on Bajaj Broking App?

Answer Field

To buy Thyrocare Technologies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Thyrocare Technologies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader